Eli Lilly news

The latest news about Eli Lilly

1. Sep 22 · Biotech GLP-1 drugmakers face lawsuits over alleged sudden vision loss risk 4
2. Aug 25 · Healthcare Innovent announces 2026 interim results and 2030 strategic vision 2
3. Aug 8 · Biotech aninews.in: “Indian pharma market grows over 12% in July, but unit growth remains subdued at 1.6%: PharmaTrac” 2
4. Aug 3 · Healthcare 933thedrive.com: “Eli Lilly to offer early access to next - gen obesity drug to some patients” 2
5. Jul 21 · Legal Novo Nordisk sues Eli Lilly over alleged false advertising 5
6. Jul 16 · Healthcare TrumpRx lists 92 brand-name drug deals, under 12% of participating firms' brands 3
7. Jul 9 · Finance Insilico Medicine issues positive profit alert for first half of 2026 2
8. Jun 29 · Biotech Medicare to start covering weight-loss drugs on July 1 under pilot 2
9. Jun 27 · Biotech Pfizer's 6.9% dividend yield draws attention as stock trades below pre-pandemic levels 1
10. Jun 25 · Healthcare Eli Lilly launches cancer drug Tanstrive in India at ₹2.15 lakh per box 2
11. Jun 23 · Healthcare White House denies Trump sought compassionate use of obesity drug 2
12. Jun 14 · Healthcare Primary care doctors raise alarm as telehealth companies get involved in obesity drugs 7
13. Mar 25 · Healthcare argentinastar.com (Big News Network): “India floods market with low - cost versions of weight - loss drugs” 1
14. Mar 24 · Healthcare India warns of misuse risk from weight-loss jabs, reports say 2
15. Mar 22 · Healthcare Eli Lilly has submitted orforglipron to the U.S. 1
16. Mar 19 · Healthcare Researchers reveal new approach to obesity drug development 6
17. Mar 19 · Healthcare Endpoints News: “Lilly’s triple-G lags Mounjaro on blood sugar lowering, first Phase 3 diabetes data suggest” 1
18. Mar 17 · Legal Delhi HC issues contempt notice to CDSCO over diabetes drug order 2
19. Mar 16 · Biotech Reports say parental demand for off-label ASD treatments has increased 17
20. Mar 14 · SaaS Seeking Alpha: “Highest and lowest quant-rated technology stocks above $10B cap after earnings season” 1
21. Mar 12 · Legal Lilly warns of impurity in compounded version of its weight-loss drug 2
22. Mar 12 · Healthcare FDA sends letter to Novo Nordisk over potential GLP-1 side effects 3
23. Mar 10 · Healthcare GLP-1 receptor agonists are being investigated as a treatment for addiction. 4
24. Mar 9 · Healthcare Seeking Alpha: “Evolv Technologies Q4 2025 Earnings Preview” 1
25. Mar 9 · Legal Hims & Hers and Novo Nordisk Settle GLP-1 Litigation, Pivot to Collaboration 7
26. Mar 9 · Healthcare Roche shares dip as oral breast cancer drug fails trial 4
27. Mar 4 · Healthcare Reports say weight loss boom is reshaping American aesthetics 2
28. Mar 4 · Healthcare Lexicon Pharmaceuticals Q4 2025 earnings preview 1
29. Mar 3 · Finance Seeking Alpha: “REX COIN Growth & Income ETF declares $0.0672 dividend” 1
30. Mar 2 · Healthcare Seeking Alpha: “Rigel Pharmaceuticals Q4 2025 Earnings Preview” 1
31. Feb 26 · Healthcare Amphastar Pharmaceuticals reports results for quarter and year ended December 31, 2025 1
32. Feb 25 · Healthcare US child obesity rates reach record high 1
33. Feb 24 · HR & workforce AbbVie commits $380 million to expand North Chicago manufacturing campus 3
34. Feb 24 · Healthcare us.cnn.com: “Novo Nordisk to slash Ozempic and Wegovy list prices by up to 50% for 2027” 4
35. Feb 19 · Finance Walmart reports earnings, outlines AI integration ambitions following $1T valuation 3

Which desks cover Eli Lilly?

1. Healthcare 30
2. Biotech 10
3. Legal 4
4. Finance 4
5. SaaS 1
6. HR & workforce 1

Which outlets cover Eli Lilly most?

1. fool.com 6
2. finance.yahoo.com 5
3. Seeking Alpha 4
4. koco.com 3
5. northcountrynow.com 2
6. ksut.org 2
7. gdnonline.com 2
8. Insider Monkey 2
9. manilatimes.net 2
10. Pr Newswire 2

Counted over the latest 40 events; one per outlet per event. Source: the reports linked on each event.

Who appears in the news with Eli Lilly?

1. Novo Nordisk 25
2. Food and Drug Administration 13
3. Zepbound 6
4. Wegovy 4
5. Mounjaro 4
6. Retatrutide 4
7. Pfizer 3
8. Semaglutide 3
9. Tirzepatide 3
10. GLP-1 Receptor Agonists 3